ciprofibrate has been researched along with Coronary Artery Disease in 4 studies
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study of the hypolipidemic efficiency, safety and tolerance of ciprofibrate (lipanor) in therapy of atherogenic hyperlipoproteinemia." | 5.08 | [Lipanor treatment of atherogenic hyperlipoproteinemia]. ( Arabidze, GG; Kukharchuk, VV; Susekov, AV; Tvorogova, MG, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Espinosa, RA | 1 |
| Rodríguez-Roa, E | 1 |
| Nagy, E | 1 |
| Mijares, ME | 1 |
| Rodríguez-Larralde, A | 1 |
| Gil, A | 1 |
| Lundberg, U | 1 |
| Carvajal, Z | 1 |
| Castillo, L | 1 |
| Arocha-Piñango, CL | 1 |
| Anber, V | 2 |
| Millar, JS | 2 |
| McConnell, M | 1 |
| Shepherd, J | 2 |
| Packard, CJ | 2 |
| Susekov, AV | 1 |
| Tvorogova, MG | 1 |
| Arabidze, GG | 1 |
| Kukharchuk, VV | 1 |
2 trials available for ciprofibrate and Coronary Artery Disease
| Article | Year |
|---|---|
[Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
Topics: Adolescent; Adult; Aged; Cholesterol; Clofibric Acid; Coronary Artery Disease; Female; Fibric Acids; | 2006 |
[Lipanor treatment of atherogenic hyperlipoproteinemia].
Topics: Cholesterol; Clofibric Acid; Coronary Artery Disease; Disease Progression; Drug Administration Sched | 1998 |
2 other studies available for ciprofibrate and Coronary Artery Disease
| Article | Year |
|---|---|
Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans.
Topics: Adult; Aged; Aorta; Apolipoproteins B; Arginine; Chondroitin Sulfates; Clofibric Acid; Coronary Arte | 1997 |
Sialic acid-containing components of lipoproteins influence lipoprotein-proteoglycan interactions.
Topics: Apolipoprotein B-100; Apolipoproteins B; Cholesterol; Chondroitin Sulfate Proteoglycans; Clofibric A | 1999 |